SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 68 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $890,000 | +82.0% | 187,423 | -8.0% | 0.00% | – |
Q4 2018 | $489,000 | -69.2% | 203,690 | -43.5% | 0.00% | -100.0% |
Q3 2018 | $1,588,000 | +15.7% | 360,774 | +89.2% | 0.00% | 0.0% |
Q2 2018 | $1,373,000 | +264.2% | 190,708 | +100.0% | 0.00% | – |
Q1 2017 | $377,000 | -29.9% | 95,345 | -13.2% | 0.00% | – |
Q4 2016 | $538,000 | -53.2% | 109,818 | -26.0% | 0.00% | -100.0% |
Q3 2016 | $1,149,000 | -11.8% | 148,406 | -36.2% | 0.00% | 0.0% |
Q2 2016 | $1,303,000 | +2.0% | 232,757 | -2.0% | 0.00% | 0.0% |
Q1 2016 | $1,277,000 | -15.2% | 237,389 | +37.3% | 0.00% | 0.0% |
Q4 2015 | $1,506,000 | +3.8% | 172,919 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,451,000 | -39.7% | 172,919 | +26.6% | 0.00% | -50.0% |
Q2 2015 | $2,406,000 | – | 136,549 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |